Integrated Research Limited Logo

Integrated Research Limited

IRI.AX

(1.5)
Stock Price

0,60 AUD

-32.58% ROA

-32.45% ROE

-2.01x PER

Market Cap.

59.367.060,00 AUD

5.1% DER

0% Yield

-29.43% NPM

Integrated Research Limited Stock Analysis

Integrated Research Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Integrated Research Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.61x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (6%), which means it has a small amount of debt compared to the ownership it holds

3 ROE

ROE in an average range (1.81%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (1.66%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-55) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Integrated Research Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Integrated Research Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Integrated Research Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Integrated Research Limited Revenue
Year Revenue Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 28.102.000 100%
2001 772.000 -3540.16%
2002 27.510.000 97.19%
2003 30.072.000 8.52%
2004 33.049.000 9.01%
2005 0 0%
2006 36.377.000 100%
2007 37.384.000 2.69%
2008 42.684.000 12.42%
2009 37.303.000 -14.43%
2010 44.592.000 16.35%
2011 48.608.000 8.26%
2012 48.859.000 0.51%
2013 53.243.000 8.23%
2014 70.279.000 24.24%
2015 84.532.000 16.86%
2016 91.169.000 7.28%
2017 91.175.000 0.01%
2018 100.820.000 9.57%
2019 110.913.000 9.1%
2020 110.913.000 0%
2020 78.493.000 -41.3%
2021 62.867.000 -24.86%
2022 62.786.000 -0.13%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Integrated Research Limited Research and Development Expenses
Year Research and Development Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 4.014.000 100%
2001 4.448.000 9.76%
2002 6.211.000 28.39%
2003 5.876.000 -5.7%
2004 5.881.000 0.09%
2005 6.687.000 12.05%
2006 6.369.000 -4.99%
2007 8.717.000 26.94%
2008 8.244.000 -5.74%
2009 8.347.000 1.23%
2010 8.949.000 6.73%
2011 10.134.000 11.69%
2012 10.777.000 5.97%
2013 11.067.000 2.62%
2014 12.431.000 10.97%
2015 0 0%
2016 14.862.000 100%
2017 15.335.000 3.08%
2018 17.888.000 14.27%
2019 17.388.000 -2.88%
2020 17.388.000 0%
2020 19.101.000 8.97%
2021 22.767.000 16.1%
2022 23.472.000 3%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Integrated Research Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 4.553.000 100%
2002 4.567.000 0.31%
2003 3.493.000 -30.75%
2004 3.494.000 0.03%
2005 3.782.000 7.62%
2006 4.103.000 7.82%
2007 4.345.000 5.57%
2008 6.142.000 29.26%
2009 4.054.000 -51.5%
2010 4.137.000 2.01%
2011 4.278.000 3.3%
2012 4.280.000 0.05%
2013 4.707.000 9.07%
2014 5.220.000 9.83%
2015 48.347.000 89.2%
2016 6.086.000 -694.4%
2017 5.849.000 -4.05%
2018 5.557.000 -5.25%
2019 6.232.000 10.83%
2020 6.232.000 0%
2020 6.235.000 0.05%
2021 6.241.000 0.1%
2022 4.470.000 -39.62%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Integrated Research Limited EBITDA
Year EBITDA Growth
1996 5.778.000
1997 10.645.000 45.72%
1998 13.796.000 22.84%
1999 12.005.000 -14.92%
2000 6.408.000 -87.34%
2001 -23.454.000 127.32%
2002 626.000 3846.65%
2003 6.913.000 90.94%
2004 7.970.000 13.26%
2005 -26.921.000 129.61%
2006 6.982.000 485.58%
2007 7.208.000 3.14%
2008 9.366.000 23.04%
2009 5.705.000 -64.17%
2010 10.483.000 45.58%
2011 11.192.000 6.33%
2012 10.523.000 -6.36%
2013 10.633.000 1.03%
2014 17.467.000 39.13%
2015 30.641.000 42.99%
2016 26.616.000 -15.12%
2017 36.948.000 27.96%
2018 41.034.000 9.96%
2019 43.705.000 6.11%
2020 31.647.000 -38.1%
2020 23.093.000 -37.04%
2021 10.400.000 -122.05%
2022 -6.169.000 268.58%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Integrated Research Limited Gross Profit
Year Gross Profit Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 28.102.000 100%
2001 772.000 -3540.16%
2002 27.510.000 97.19%
2003 30.072.000 8.52%
2004 33.049.000 9.01%
2005 0 0%
2006 36.377.000 100%
2007 37.384.000 2.69%
2008 42.684.000 12.42%
2009 37.303.000 -14.43%
2010 44.592.000 16.35%
2011 48.608.000 8.26%
2012 48.859.000 0.51%
2013 53.243.000 8.23%
2014 70.279.000 24.24%
2015 84.532.000 16.86%
2016 91.169.000 7.28%
2017 91.175.000 0.01%
2018 100.820.000 9.57%
2019 110.913.000 9.1%
2020 110.913.000 0%
2020 78.493.000 -41.3%
2021 62.867.000 -24.86%
2022 62.786.000 -0.13%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Integrated Research Limited Net Profit
Year Net Profit Growth
1996 2.262.000
1997 4.243.000 46.69%
1998 5.321.000 20.26%
1999 4.875.000 -9.15%
2000 5.020.000 2.89%
2001 6.523.000 23.04%
2002 1.072.000 -508.49%
2003 4.455.000 75.94%
2004 6.199.000 28.13%
2005 7.003.000 11.48%
2006 5.433.000 -28.9%
2007 5.776.000 5.94%
2008 7.863.000 26.54%
2009 5.401.000 -45.58%
2010 7.465.000 27.65%
2011 9.035.000 17.38%
2012 9.078.000 0.47%
2013 8.489.000 -6.94%
2014 14.251.000 40.43%
2015 16.029.000 11.09%
2016 18.520.000 13.45%
2017 19.180.000 3.44%
2018 21.851.000 12.22%
2019 24.054.000 9.16%
2020 24.054.000 0%
2020 7.935.000 -203.14%
2021 1.545.000 -413.59%
2022 -64.885.996 102.38%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Integrated Research Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Integrated Research Limited Free Cashflow
Year Free Cashflow Growth
1996 2.418.000
1997 2.866.000 15.63%
1998 7.974.000 64.06%
1999 379.000 -2003.96%
2000 3.205.000 88.17%
2001 817.000 -292.29%
2002 3.905.000 79.08%
2003 3.812.000 -2.44%
2004 4.931.000 22.69%
2005 4.558.000 -8.18%
2006 3.649.000 -24.91%
2007 5.588.000 34.7%
2008 7.119.000 21.51%
2009 7.381.000 3.55%
2010 13.214.000 44.14%
2011 7.177.000 -84.12%
2012 8.958.000 19.88%
2013 7.270.000 -23.22%
2014 11.252.000 35.39%
2015 6.190.000 -81.78%
2016 16.691.000 62.91%
2017 8.733.000 -91.13%
2018 8.661.000 -0.83%
2019 8.948.000 3.21%
2020 8.834.000 -1.29%
2021 5.142.000 -71.8%
2022 6.350.000 19.02%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Integrated Research Limited Operating Cashflow
Year Operating Cashflow Growth
1996 2.569.000
1997 3.063.000 16.13%
1998 8.533.000 64.1%
1999 1.426.000 -498.39%
2000 3.773.000 62.21%
2001 1.131.000 -233.6%
2002 4.496.000 74.84%
2003 4.178.000 -7.61%
2004 5.733.000 27.12%
2005 5.085.000 -12.74%
2006 6.113.000 16.82%
2007 5.946.000 -2.81%
2008 7.644.000 22.21%
2009 8.339.000 8.33%
2010 13.854.000 39.81%
2011 14.646.000 5.41%
2012 17.456.000 16.1%
2013 16.019.000 -8.97%
2014 21.419.000 25.21%
2015 16.218.000 -32.07%
2016 26.162.000 38.01%
2017 21.442.000 -22.01%
2018 21.237.000 -0.97%
2019 24.152.000 12.07%
2020 21.076.000 -14.59%
2021 16.940.000 -24.42%
2022 6.406.500 -164.42%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Integrated Research Limited Capital Expenditure
Year Capital Expenditure Growth
1996 151.000
1997 197.000 23.35%
1998 559.000 64.76%
1999 1.047.000 46.61%
2000 568.000 -84.33%
2001 314.000 -80.89%
2002 591.000 46.87%
2003 366.000 -61.48%
2004 802.000 54.36%
2005 527.000 -52.18%
2006 2.464.000 78.61%
2007 358.000 -588.27%
2008 525.000 31.81%
2009 958.000 45.2%
2010 640.000 -49.69%
2011 7.469.000 91.43%
2012 8.498.000 12.11%
2013 8.749.000 2.87%
2014 10.167.000 13.95%
2015 10.028.000 -1.39%
2016 9.471.000 -5.88%
2017 12.709.000 25.48%
2018 12.576.000 -1.06%
2019 15.204.000 17.28%
2020 12.242.000 -24.2%
2021 11.798.000 -3.76%
2022 56.500 -20781.42%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Integrated Research Limited Equity
Year Equity Growth
1996 0
1997 0 0%
1998 7.620.000 100%
1999 9.336.000 18.38%
2000 12.430.000 24.89%
2001 15.614.000 20.39%
2002 15.424.000 -1.23%
2003 18.644.000 17.27%
2004 21.574.000 13.58%
2005 23.288.000 7.36%
2006 24.153.000 3.58%
2007 23.791.000 -1.52%
2008 27.246.000 12.68%
2009 24.502.000 -11.2%
2010 27.357.000 10.44%
2011 29.233.000 6.42%
2012 30.010.000 2.59%
2013 30.747.000 2.4%
2014 36.132.000 14.9%
2015 41.046.000 11.97%
2016 48.520.000 15.4%
2017 57.838.000 16.11%
2018 69.827.000 17.17%
2019 82.522.000 15.38%
2020 83.342.000 0.98%
2021 87.113.000 4.33%
2022 59.874.000 -45.49%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Integrated Research Limited Assets
Year Assets Growth
1996 0
1997 0 0%
1998 18.251.000 100%
1999 21.409.000 14.75%
2000 25.519.000 16.11%
2001 31.303.000 18.48%
2002 30.014.000 -4.29%
2003 34.053.000 11.86%
2004 35.595.000 4.33%
2005 39.642.000 10.21%
2006 41.195.000 3.77%
2007 40.326.000 -2.15%
2008 47.191.000 14.55%
2009 44.254.000 -6.64%
2010 46.324.000 4.47%
2011 52.459.000 11.69%
2012 57.858.000 9.33%
2013 57.983.000 0.22%
2014 76.258.000 23.96%
2015 88.960.000 14.28%
2016 99.550.000 10.64%
2017 110.572.000 9.97%
2018 113.521.000 2.6%
2019 139.837.000 18.82%
2020 135.075.000 -3.53%
2021 124.444.000 -8.54%
2022 89.712.000 -38.71%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Integrated Research Limited Liabilities
Year Liabilities Growth
1996 0
1997 0 0%
1998 10.631.000 100%
1999 12.073.000 11.94%
2000 13.089.000 7.76%
2001 15.689.000 16.57%
2002 14.590.000 -7.53%
2003 15.409.000 5.32%
2004 14.021.000 -9.9%
2005 16.354.000 14.27%
2006 17.042.000 4.04%
2007 16.535.000 -3.07%
2008 19.945.000 17.1%
2009 19.752.000 -0.98%
2010 18.967.000 -4.14%
2011 23.226.000 18.34%
2012 27.848.000 16.6%
2013 27.236.000 -2.25%
2014 40.126.000 32.12%
2015 47.914.000 16.25%
2016 51.030.000 6.11%
2017 52.734.000 3.23%
2018 43.694.000 -20.69%
2019 57.315.000 23.77%
2020 51.733.000 -10.79%
2021 37.331.000 -38.58%
2022 29.838.000 -25.11%

Integrated Research Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.4
Net Income per Share
-0.17
Price to Earning Ratio
-2.01x
Price To Sales Ratio
0.85x
POCF Ratio
4.26
PFCF Ratio
4.4
Price to Book Ratio
0.98
EV to Sales
0.63
EV Over EBITDA
-87.64
EV to Operating CashFlow
3.17
EV to FreeCashFlow
3.25
Earnings Yield
-0.5
FreeCashFlow Yield
0.23
Market Cap
0,06 Bil.
Enterprise Value
0,04 Bil.
Graham Number
1.15
Graham NetNet
0.12

Income Statement Metrics

Net Income per Share
-0.17
Income Quality
-0.47
ROE
-0.42
Return On Assets
-0.22
Return On Capital Employed
0.12
Net Income per EBT
1.04
EBT Per Ebit
-2.26
Ebit per Revenue
0.13
Effective Tax Rate
-0.04

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0.34
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.45
Operating Profit Margin
0.13
Pretax Profit Margin
-0.28
Net Profit Margin
-0.29

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.08
Free CashFlow per Share
0.08
Capex to Operating CashFlow
-0.02
Capex to Revenue
-0
Capex to Depreciation
-0.21
Return on Invested Capital
-0.02
Return on Tangible Assets
-0.33
Days Sales Outstanding
213.86
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
1.71
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,11
Book Value per Share
0,35
Tangible Book Value per Share
0.35
Shareholders Equity per Share
0.35
Interest Debt per Share
0.02
Debt to Equity
0.05
Debt to Assets
0.03
Net Debt to EBITDA
30.97
Current Ratio
2.32
Tangible Asset Value
0,06 Bil.
Net Current Asset Value
0,03 Bil.
Invested Capital
0.05
Working Capital
0,04 Bil.
Intangibles to Total Assets
0
Average Receivables
0,02 Bil.
Average Payables
0,01 Bil.
Average Inventory
1177500
Debt to Market Cap
0.05

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Integrated Research Limited Dividends
Year Dividends Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%

Integrated Research Limited Profile

About Integrated Research Limited

Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, and unified communication and payment networks. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications. It also provides testing, maintenance, and professional services, as well as software as a service solution. The company offers its products in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, as well as through channel-driven distribution networks internationally. It serves stock exchanges, banks, credit card companies, telecommunications carriers, service providers, and manufacturers. The company was incorporated in 1988 and is based in North Sydney, Australia.

CEO
Mr. John Ruthven M.A.I.C.D.
Employee
175
Address
100 Pacific Highway
North Sydney, 2060

Integrated Research Limited Executives & BODs

Integrated Research Limited Executives & BODs
# Name Age
1 Mr. John Ruthven M.A.I.C.D.
MD, Chief Executive Officer & Director
70
2 Mr. Michael Tomkins
Chief Technology Officer
70
3 Mr. Stuart Matthewman
Chief Marketing Officer
70
4 Mr. Christian Shaw CPA
Chief Financial Officer
70
5 Ms. Donna Williams
Chief People Officer
70
6 Mr. Jason Barker B.A., BA (Hons)
Senior Vice President of International Business
70
7 Mr. Stephen John Killelea A.M.
Advisor
70
8 Mr. Marco Cantamessi
Senior Vice President of Americas
70
9 Mr. William Witherow B.A., J.D.
Company Secretary & General Counsel
70

Integrated Research Limited Competitors